01After radical prostatectomy
One program in men after radical prostatectomy enrolled 427 men. The primary endpoints were assessed at 3 months. EF Domain scores were 15 on LEVITRA 10 mg and 9 on placebo. SEP2 rates were 47% on 10 mg and 22% on placebo. SEP3 rates were 37% on 10 mg and 10% on placebo.